Kaleido Biosciences, Inc.
KLDO · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13.2% | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -113.6% | -5,640.2% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,707.6% | -7,896.9% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -8,178.3% | -8,371.3% | – | – |
| EPS Diluted | -2.16 | -2.44 | -3.31 | -2.1 |
| % Growth | 11.5% | 26.3% | -57.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |